AVEO PHARMACEUTICALS INC (AVEO)

US0535883070 - Common Stock

15  0 (0%)

After market: 15 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
94.32M42.30M6.00M28.80M5.40M
Cost Of Goods
11.50M4.74MN/AN/AN/A
Gross Profit
82.82M37.56MN/AN/AN/A
Operating Expenses
107.32M87.11M44.90M29.20M31.50M
Research and Development
39.67M26.30M22.70M18.00M20.70M
Selling, General, and Administrative Expenses
67.64M60.81M22.20M11.20M10.80M
Operating Income
-24.49M-49.55M-38.90M-400.00K-26.10M
Interest Income/Expense
-4.60M-3.85M3.30M9.80M17.70M
Other Income/Expense
N/A58.00K0.000.002.30M
Non Recurring Items
N/AN/AN/A0.00700.00K
Income Before Taxes
-29.04M-53.34M-35.60M9.40M-5.30M
Income Tax
N/AN/A0.000.000.00
Net Income
-29.04M-53.34M-35.60M9.40M-5.30M
EBITDA
-24.43M-49.49M-38.88MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-0.84-1.63-1.660.61-0.44
Non GAAP EPS
-0.84-1.72-1.710.62-0.50
 
Statistics
Gross Profit Margin
87.81%88.80%N/AN/AN/A
Profit Margin
-30.79%-126.12%-593.33%32.64%-98.15%
Operating Profit Margin
-25.97%-117.16%-648.33%-1.39%-483.33%

All data in USD

Charts